MAFA
AVNS

MJT & Associates Financial Advisory’s Avanos Medical AVNS Stock Holding History

MJT & Associates Financial Advisory’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-162
Closed -$1.87K – 450
2025
Q3 		$1.87K Hold
162
– – ﹤0.01% 396
2025
Q2 		$1.98K Hold
162
– – ﹤0.01% 395
2025
Q1 		$2.32K Buy
+162
New +$2.53K ﹤0.01% 391

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MJT & Associates Financial Advisory's AVNS Position: Q4 2025 in Review

MJT & Associates Financial Advisory sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 162 shares — an estimated $1.87K sold.

MJT & Associates Financial Advisory first reported a position in AVNS in Q1 2025 and held it in 3 quarters. The position peaked at $2.32K in Q1 2025. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • MJT & Associates Financial Advisory reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • MJT & Associates Financial Advisory sold 162 Avanos Medical shares in Q4 2025, an estimated $1.87K.
  • MJT & Associates Financial Advisory first reported a position in Avanos Medical in Q1 2025 and held it in 3 quarters.
  • MJT & Associates Financial Advisory's Avanos Medical position peaked at $2.32K in Q1 2025.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on MJT & Associates Financial Advisory's 13F filing for Q4 2025, filed 10 Feb 2026.